000025990 000__ 01580cam\a2200421\i\4500
000025990 001__ 25990
000025990 003__ SzGeWIPO
000025990 005__ 20240708162338.0
000025990 008__ 080424s2009    xx |||||r|||| 00| 0 eng d
000025990 035__ $$a(wipo)0
000025990 035__ $$a(OCoLC)1158943121
000025990 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000025990 043__ $$ae-uk---
000025990 050_4 $$aK3925.B56$$bA152
000025990 08204 $$a344.095$$221
000025990 084__ $$aGB 110 
000025990 1001_ $$aBisschop, K.,$$eauthor.
000025990 24510 $$aSPC entitlement :$$bEJC rules in favor of drug innovators in interpreting SPC regulations for medicinal and plant protection products /$$cBisschop, K., Schrijvers, K.
000025990 264_1 $$a[Place of publication not identified] :$$b[publisher not identified],$$c2009.
000025990 300__ $$a1 volume ([6] pages) ;$$c[28] cm.
000025990 336__ $$atext$$btxt$$2rdacontent
000025990 337__ $$aunmediated$$bn$$2rdamedia
000025990 338__ $$avolume$$bnc$$2rdacarrier
000025990 4901_ $$aBio-Science Law Review,$$x1365-8867 ;$$vGB 110 2009 Vol 10 No 5, pages 187-192
000025990 650_0 $$aBiotechnology$$zEurope$$xPatents.
000025990 650_4 $$aCase law$$zNetherlands
000025990 650_4 $$aPlant protection
000025990 650_4 $$aMedicine
000025990 650_4 $$aLicensing$$zUnited Kingdom
000025990 650_6 $$aGénie génétique$$xDroit.
000025990 650_6 $$aBiotechnologie.
000025990 651_0 $$aUnited Kingdom$$xCommerce$$xLaw and legislation.
000025990 7001_ $$aSchrijvers, K.
000025990 830_0 $$aBio-Science Law Review ;$$vGB 110 2009 Vol 10 No 5, pages 187-192.
000025990 903__ $$aBio-Science Law Review.
000025990 904__ $$aJournal article
000025990 942__ $$cART$$jGB 110 2009 Vol 10 No 5$$2ddc
000025990 952__ $$w2010-07-30$$p2010-0675$$u40172$$bMAIN$$10$$kGB 110 $$v2010-07-30$$70$$cMain library$$yART
000025990 980__ $$aBIB
000025990 999__ $$c28364$$d28364